Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
neuroscience
Pharma
AbbVie notches FDA nod for Ceverel asset Juvmo in Parkinson's
Through a trial setback looms in the background, AbbVie’s $8.7 billion bet on Cerevel Therapeutics has paid off with its first approval from the FDA.
Fraiser Kansteiner
Sep 28, 2026 8:15am
Lundbeck relocating US headquarters to Boston in innovation move
Sep 25, 2026 10:41am
AbbVie chips in for neurology advocacy through PGA Tour campaign
Sep 15, 2026 9:27am
How Lundbeck’s CEO aims to keep firm ‘punching above its weight’
Aug 21, 2026 11:30am
Novartis charts another 60 layoffs at US corporate outpost
May 4, 2026 11:09am
After Avadel setback, Lundbeck signals future M&A rigor
Jan 22, 2026 11:13am
